FOOD RESEARCH INTERNATIONAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2022-04-14 ms5000001141199682

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：乳脂
经验分享：2021.3.16 Submitted to journal/ With editor
2021.4.05 Under review (此状态时间更新多次)
2021.6.12 Major revision and reconsideration (二个审稿人意见)
2021.6.24 With editor
2021.6.27 Under review
2021.9.01 Major revision and reconsideration (又加了三个审稿人意见)
2021.10.06 Under review
2022.2.14 accept
过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2022-11-29 阔阔来自四川省

11月14号投一篇，到现在Uneed review，希望尽快有好的结果

42 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2022-08-12 ms4000001582217878

审稿速度:3.0 | 投稿命中率:25.0
经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2022-05-05 ms5000001105610949

偏重的研究方向：食品活性成分
经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2021-12-28 小动量

讨论中我和之前发表文章结果不一致怎么处理？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

讨论中一般可以讨论什么？

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2019-09-04 ms8259664520863131

审稿速度:2.0
经验分享：aug 10, 2019：submit
aug 12, 2019：with editor
一直到现在with editor状态，

81 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2019-12-19 ms8364037627693300

审稿速度:2.0
经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2020-04-13 zhedong

审稿速度:1.0 | 投稿命中率:25.0
经验分享：3.20With editor 4.11 Completed

120 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211168, encodeId=e0fb12111689a, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：乳脂 经验分享：2021.3.16 Submitted to journal/ With editor 2021.4.05 Under review (此状态时间更新多次) 2021.6.12 Major revision and reconsideration (二个审稿人意见) 2021.6.24 With editor 2021.6.27 Under review 2021.9.01 Major revision and reconsideration (又加了三个审稿人意见) 2021.10.06 Under review 2022.2.14 accept 过程很漫长，将近一年，五个审稿人给了很多意见，也深刻意识到写作方面的问题及注意事项，只是审稿周期很长，最后一次，将近5个月，催过一次，还好结果是好的，希望杂志越来越好，审稿越来越快！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6e15629547, createdName=ms5000001141199682, createdTime=Thu Apr 14 16:04:37 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103261, encodeId=428e21032617a, content=11月14号投一篇，到现在Uneed review，希望尽快有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb995509854, createdName=阔阔, createdTime=Tue Nov 29 11:31:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1238266, encodeId=71b31238266fc, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：送审速度蛮快的，审稿意见直接说没有创新性，说有研究过的了，附了几篇已发表文章，一看和我做的不一样啊。估计看人脉。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc7f6477604, createdName=ms4000001582217878, createdTime=Fri Aug 12 13:39:05 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217202, encodeId=bfac121e202ad, content=偏重的研究方向：食品活性成分 经验分享：22.4.18 投 22.4.28 送审 22.5.3 送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Thu May 05 22:26:46 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090654, encodeId=4371109065450, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090653, encodeId=501c10906533f, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853585, encodeId=35c885358555, content=审稿速度:2.0 经验分享：aug 10, 2019：submit aug 12, 2019：with editor 一直到现在with editor状态， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38035414085, createdName=ms8259664520863131, createdTime=Wed Sep 04 19:07:08 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855988, encodeId=25e985598893, content=审稿速度:2.0 经验分享：12.2号提交，12.4号with editor，截值12.19号没有任何变动。看之前网友分享，感觉运气比较重要，期待录用，保毕业用的呀，拜托~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74455414066, createdName=ms8364037627693300, createdTime=Thu Dec 19 09:40:42 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588738, encodeId=c397588e38e4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：3.20With editor 4.11 Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/w23UmMzTJVtWU3wpxFuaAh1nauq9a4ScBxQTTKWJkXFgxJBtm2Czq3hW9zq34sPpagQT8lkSr4rrW13XMTF6ibg/132, createdBy=77195315865, createdName=zhedong, createdTime=Mon Apr 13 00:00:00 CST 2020, time=2020-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591355, encodeId=50bb59135586, content=with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/672b4f4d01fedc8d59c87c91368afb65.jpg, createdBy=e4ba1736279, createdName=autumndz, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2020-05-21 autumndz

with editor 10天后，才分配了编辑，under review，请问送审后一般多长时间出一审结果

118 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务